APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Exosome Manufacturing Service

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Exosome Manufacturing Service Market Analysis and Forecast 2026-2032

Report ID 17413729026 March 2026192 pages

Choose your research edition.

Industry ResearchExosome Manufacturing Service Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Exosome Manufacturing Service Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Exosome Manufacturing Service Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Exosome Manufacturing Service Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Exosome Manufacturing Service Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Exosome Manufacturing Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Exosome Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Exosome Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Exosome Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Exosome Manufacturing Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Exosome Manufacturing Service include Guidon (Beijing) Pharmaceutical Technology, Cytoniche, EverZom, Lonza, RoosterBio, SBI, Creative-Biolabs, Esco Aster and EXO Biologics, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Exosome Manufacturing Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Exosome Manufacturing Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Exosome Manufacturing Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Exosome Manufacturing Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Exosome Manufacturing Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Exosome Manufacturing Service revenue, projected growth trends, production technology, application and end-user industry.

Exosome Manufacturing Service Segment by Company

Guidon (Beijing) Pharmaceutical Technology

Cytoniche

EverZom

Lonza

RoosterBio

SBI

Creative-Biolabs

Esco Aster

EXO Biologics

Eppendorf

Aethlon Medical

Exosome Manufacturing Service Segment by Type

Human Embryonic Kidney Cell-Derived Exosomes

Bone Marrow Stem Cell-Derived Exosomes

Immature Dendritic Cell-Derived Exosomes

Milk-Derived Exosomes

Red Blood Cell-Derived Exosomes

Others

Exosome Manufacturing Service Segment by Application

Laboratory

Pharmaceutical Companies

Others

Exosome Manufacturing Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Exosome Manufacturing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Exosome Manufacturing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Exosome Manufacturing Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Exosome Manufacturing Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Exosome Manufacturing Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosome Manufacturing Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Exosome Manufacturing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Human Embryonic Kidney Cell-Derived Exosomes Major Player Table 3. Bone Marrow Stem Cell-Derived Exosomes Major Player Table 4. Immature Dendritic Cell-Derived Exosomes Major Player Table 5. Milk-Derived Exosomes Major Player Table 6. Red Blood Cell-Derived Exosomes Major Player Table 7. Others Major Player Table 8. Global Exosome Manufacturing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 9. Laboratory Major Player Table 10. Pharmaceutical Companies Major Player Table 11. Others Major Player Table 12. Exosome Manufacturing Service Industry Trends Table 13. Exosome Manufacturing Service Industry Drivers Table 14. Exosome Manufacturing Service Industry Opportunities and Challenges Table 15. Exosome Manufacturing Service Industry Restraints Table 16. Global Exosome Manufacturing Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Exosome Manufacturing Service Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Exosome Manufacturing Service Market Share by Region (2021-2026) Table 19. Global Exosome Manufacturing Service Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Exosome Manufacturing Service Market Share by Region (2027-2032) Table 21. Global Exosome Manufacturing Service Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Exosome Manufacturing Service Revenue Market Share by Players (2021-2026) Table 23. Global Exosome Manufacturing Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Exosome Manufacturing Service Key Players Headquarters & Area Served Table 25. Global Exosome Manufacturing Service Players, Product Type & Application Table 26. Global Exosome Manufacturing Service Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Exosome Manufacturing Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Exosome Manufacturing Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Exosome Manufacturing Service Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Exosome Manufacturing Service Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Exosome Manufacturing Service Revenue Market Share by Type (2021-2026) Table 33. Global Exosome Manufacturing Service Revenue Market Share by Type (2027-2032) Table 34. Global Exosome Manufacturing Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Exosome Manufacturing Service Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Exosome Manufacturing Service Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Exosome Manufacturing Service Revenue Market Share by Application (2021-2026) Table 38. Global Exosome Manufacturing Service Revenue Market Share by Application (2027-2032) Table 39. Guidon (Beijing) Pharmaceutical Technology Company Information Table 40. Guidon (Beijing) Pharmaceutical Technology Business Overview Table 41. Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Portfolio Table 43. Guidon (Beijing) Pharmaceutical Technology Recent Development Table 44. Cytoniche Company Information Table 45. Cytoniche Business Overview Table 46. Cytoniche Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Cytoniche Exosome Manufacturing Service Product Portfolio Table 48. Cytoniche Recent Development Table 49. EverZom Company Information Table 50. EverZom Business Overview Table 51. EverZom Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. EverZom Exosome Manufacturing Service Product Portfolio Table 53. EverZom Recent Development Table 54. Lonza Company Information Table 55. Lonza Business Overview Table 56. Lonza Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Lonza Exosome Manufacturing Service Product Portfolio Table 58. Lonza Recent Development Table 59. RoosterBio Company Information Table 60. RoosterBio Business Overview Table 61. RoosterBio Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. RoosterBio Exosome Manufacturing Service Product Portfolio Table 63. RoosterBio Recent Development Table 64. SBI Company Information Table 65. SBI Business Overview Table 66. SBI Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. SBI Exosome Manufacturing Service Product Portfolio Table 68. SBI Recent Development Table 69. Creative-Biolabs Company Information Table 70. Creative-Biolabs Business Overview Table 71. Creative-Biolabs Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Creative-Biolabs Exosome Manufacturing Service Product Portfolio Table 73. Creative-Biolabs Recent Development Table 74. Esco Aster Company Information Table 75. Esco Aster Business Overview Table 76. Esco Aster Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Esco Aster Exosome Manufacturing Service Product Portfolio Table 78. Esco Aster Recent Development Table 79. EXO Biologics Company Information Table 80. EXO Biologics Business Overview Table 81. EXO Biologics Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. EXO Biologics Exosome Manufacturing Service Product Portfolio Table 83. EXO Biologics Recent Development Table 84. Eppendorf Company Information Table 85. Eppendorf Business Overview Table 86. Eppendorf Exosome Manufacturing Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Eppendorf Exosome Manufacturing Service Product Portfolio Table 88. Eppendorf Recent Development Table 89. Aethlon Medical Company Information Table 90. Aethlon Medical Business Overview Table 91. Aethlon Medical Exosome Manufacturing Service Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Aethlon Medical Exosome Manufacturing Service Product Portfolio Table 93. Aethlon Medical Recent Development Table 94. North America Exosome Manufacturing Service Revenue by Type (2021-2026) & (US$ Million) Table 95. North America Exosome Manufacturing Service Revenue by Type (2027-2032) & (US$ Million) Table 96. North America Exosome Manufacturing Service Revenue by Application (2021-2026) & (US$ Million) Table 97. North America Exosome Manufacturing Service Revenue by Application (2027-2032) & (US$ Million) Table 98. North America Exosome Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. North America Exosome Manufacturing Service Revenue by Country (2021-2026) & (US$ Million) Table 100. North America Exosome Manufacturing Service Revenue by Country (US$ Million) & (2027-2032) Table 101. Europe Exosome Manufacturing Service Revenue by Type (2021-2026) & (US$ Million) Table 102. Europe Exosome Manufacturing Service Revenue by Type (2027-2032) & (US$ Million) Table 103. Europe Exosome Manufacturing Service Revenue by Application (2021-2026) & (US$ Million) Table 104. Europe Exosome Manufacturing Service Revenue by Application (2027-2032) & (US$ Million) Table 105. Europe Exosome Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. Europe Exosome Manufacturing Service Revenue by Country (2021-2026) & (US$ Million) Table 107. Europe Exosome Manufacturing Service Revenue by Country (US$ Million) & (2027-2032) Table 108. China Exosome Manufacturing Service Revenue by Type (2021-2026) & (US$ Million) Table 109. China Exosome Manufacturing Service Revenue by Type (2027-2032) & (US$ Million) Table 110. China Exosome Manufacturing Service Revenue by Application (2021-2026) & (US$ Million) Table 111. China Exosome Manufacturing Service Revenue by Application (2027-2032) & (US$ Million) Table 112. Asia Exosome Manufacturing Service Revenue by Type (2021-2026) & (US$ Million) Table 113. Asia Exosome Manufacturing Service Revenue by Type (2027-2032) & (US$ Million) Table 114. Asia Exosome Manufacturing Service Revenue by Application (2021-2026) & (US$ Million) Table 115. Asia Exosome Manufacturing Service Revenue by Application (2027-2032) & (US$ Million) Table 116. Asia Exosome Manufacturing Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Asia Exosome Manufacturing Service Revenue by Region (US$ Million) & (2021-2026) Table 118. Asia Exosome Manufacturing Service Revenue by Region (US$ Million) & (2027-2032) Table 119. SAMEA Exosome Manufacturing Service Revenue by Type (2021-2026) & (US$ Million) Table 120. SAMEA Exosome Manufacturing Service Revenue by Type (2027-2032) & (US$ Million) Table 121. SAMEA Exosome Manufacturing Service Revenue by Application (2021-2026) & (US$ Million) Table 122. SAMEA Exosome Manufacturing Service Revenue by Application (2027-2032) & (US$ Million) Table 123. SAMEA Exosome Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. SAMEA Exosome Manufacturing Service Revenue by Country (2021-2026) & (US$ Million) Table 125. SAMEA Exosome Manufacturing Service Revenue by Country (US$ Million) & (2027-2032) Table 126. Research Programs/Design for This Report Table 127. Authors List of This Report Table 128. Secondary Sources Table 129. Primary Sources List of Figures Figure 1. Exosome Manufacturing Service Image Figure 2. Global Exosome Manufacturing Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Exosome Manufacturing Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Human Embryonic Kidney Cell-Derived Exosomes Image Figure 5. Bone Marrow Stem Cell-Derived Exosomes Image Figure 6. Immature Dendritic Cell-Derived Exosomes Image Figure 7. Milk-Derived Exosomes Image Figure 8. Red Blood Cell-Derived Exosomes Image Figure 9. Others Image Figure 10. Global Exosome Manufacturing Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Exosome Manufacturing Service Market Size Share 2021 VS 2025 VS 2032 Figure 12. Laboratory Image Figure 13. Pharmaceutical Companies Image Figure 14. Others Image Figure 15. Global Exosome Manufacturing Service Market Size (US$ Million) & (2021-2032) Figure 16. Global Exosome Manufacturing Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Exosome Manufacturing Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Exosome Manufacturing Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Exosome Manufacturing Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Exosome Manufacturing Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Exosome Manufacturing Service Revenue Market Share by Type (2021-2032) Figure 23. Global Exosome Manufacturing Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Exosome Manufacturing Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Exosome Manufacturing Service Revenue Market Share by Application (2021-2032) Figure 26. North America Exosome Manufacturing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Exosome Manufacturing Service Revenue Share by Type (2021-2032) Figure 28. North America Exosome Manufacturing Service Revenue Share by Application (2021-2032) Figure 29. North America Exosome Manufacturing Service Revenue Share by Country (2021-2032) Figure 30. United States Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Exosome Manufacturing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Exosome Manufacturing Service Revenue Share by Type (2021-2032) Figure 35. Europe Exosome Manufacturing Service Revenue Share by Application (2021-2032) Figure 36. Europe Exosome Manufacturing Service Revenue Share by Country (2021-2032) Figure 37. Germany Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Exosome Manufacturing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Exosome Manufacturing Service Revenue Share by Type (2021-2032) Figure 47. China Exosome Manufacturing Service Revenue Share by Application (2021-2032) Figure 48. Asia Exosome Manufacturing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Exosome Manufacturing Service Revenue Share by Type (2021-2032) Figure 50. Asia Exosome Manufacturing Service Revenue Share by Application (2021-2032) Figure 51. Asia Exosome Manufacturing Service Revenue Share by Region (2021-2032) Figure 52. Japan Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Exosome Manufacturing Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Exosome Manufacturing Service Revenue Share by Type (2021-2032) Figure 60. SAMEA Exosome Manufacturing Service Revenue Share by Application (2021-2032) Figure 61. SAMEA Exosome Manufacturing Service Revenue Share by Country (2021-2032) Figure 62. Brazil Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Exosome Manufacturing Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Human Embryonic Kidney Cell-Derived Exosomes
  • Bone Marrow Stem Cell-Derived Exosomes
  • Immature Dendritic Cell-Derived Exosomes
  • Milk-Derived Exosomes
  • Red Blood Cell-Derived Exosomes
  • Others
Applications
  • Laboratory
  • Pharmaceutical Companies
  • Others
Companies covered
  • Guidon (Beijing) Pharmaceutical Technology
  • Cytoniche
  • EverZom
  • Lonza
  • RoosterBio
  • SBI
  • Creative-Biolabs
  • Esco Aster
  • EXO Biologics
  • Eppendorf
  • Aethlon Medical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Exosome Manufacturing Service Market by Type
  3. 1.2.1 Global Exosome Manufacturing Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Human Embryonic Kidney Cell-Derived Exosomes
  5. 1.2.3 Bone Marrow Stem Cell-Derived Exosomes
  6. 1.2.4 Immature Dendritic Cell-Derived Exosomes
  7. 1.2.5 Milk-Derived Exosomes
  8. 1.2.6 Red Blood Cell-Derived Exosomes
  9. 1.2.7 Others
  10. 1.3 Exosome Manufacturing Service Market by Application
  11. 1.3.1 Global Exosome Manufacturing Service Market Size by Application, 2021 VS 2025 VS 2032
  12. 1.3.2 Laboratory
  13. 1.3.3 Pharmaceutical Companies
  14. 1.3.4 Others
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Exosome Manufacturing Service Market Dynamics
  1. 2.1 Exosome Manufacturing Service Industry Trends
  2. 2.2 Exosome Manufacturing Service Industry Drivers
  3. 2.3 Exosome Manufacturing Service Industry Opportunities and Challenges
  4. 2.4 Exosome Manufacturing Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Exosome Manufacturing Service Market Perspective (2021-2032)
  2. 3.2 Global Exosome Manufacturing Service Growth Trends by Region
  3. 3.2.1 Global Exosome Manufacturing Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Exosome Manufacturing Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Exosome Manufacturing Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Exosome Manufacturing Service Revenue by Players
  2. 4.1.1 Global Exosome Manufacturing Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Exosome Manufacturing Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Exosome Manufacturing Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Exosome Manufacturing Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Exosome Manufacturing Service Key Players Headquarters & Area Served
  7. 4.4 Global Exosome Manufacturing Service Players, Product Type & Application
  8. 4.5 Global Exosome Manufacturing Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Exosome Manufacturing Service Market CR5 and HHI
  11. 4.6.3 2025 Exosome Manufacturing Service Tier 1, Tier 2, and Tier 3
5 Exosome Manufacturing Service Market Size by Type
  1. 5.1 Global Exosome Manufacturing Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Exosome Manufacturing Service Revenue by Type (2021-2032)
  3. 5.3 Global Exosome Manufacturing Service Revenue Market Share by Type (2021-2032)
6 Exosome Manufacturing Service Market Size by Application
  1. 6.1 Global Exosome Manufacturing Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Exosome Manufacturing Service Revenue by Application (2021-2032)
  3. 6.3 Global Exosome Manufacturing Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Guidon (Beijing) Pharmaceutical Technology
  2. 7.1.1 Guidon (Beijing) Pharmaceutical Technology Company Information
  3. 7.1.2 Guidon (Beijing) Pharmaceutical Technology Business Overview
  4. 7.1.3 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Guidon (Beijing) Pharmaceutical Technology Exosome Manufacturing Service Product Portfolio
  6. 7.1.5 Guidon (Beijing) Pharmaceutical Technology Recent Developments
  7. 7.2 Cytoniche
  8. 7.2.1 Cytoniche Company Information
  9. 7.2.2 Cytoniche Business Overview
  10. 7.2.3 Cytoniche Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Cytoniche Exosome Manufacturing Service Product Portfolio
  12. 7.2.5 Cytoniche Recent Developments
  13. 7.3 EverZom
  14. 7.3.1 EverZom Company Information
  15. 7.3.2 EverZom Business Overview
  16. 7.3.3 EverZom Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 EverZom Exosome Manufacturing Service Product Portfolio
  18. 7.3.5 EverZom Recent Developments
  19. 7.4 Lonza
  20. 7.4.1 Lonza Company Information
  21. 7.4.2 Lonza Business Overview
  22. 7.4.3 Lonza Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Lonza Exosome Manufacturing Service Product Portfolio
  24. 7.4.5 Lonza Recent Developments
  25. 7.5 RoosterBio
  26. 7.5.1 RoosterBio Company Information
  27. 7.5.2 RoosterBio Business Overview
  28. 7.5.3 RoosterBio Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 RoosterBio Exosome Manufacturing Service Product Portfolio
  30. 7.5.5 RoosterBio Recent Developments
  31. 7.6 SBI
  32. 7.6.1 SBI Company Information
  33. 7.6.2 SBI Business Overview
  34. 7.6.3 SBI Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 SBI Exosome Manufacturing Service Product Portfolio
  36. 7.6.5 SBI Recent Developments
  37. 7.7 Creative-Biolabs
  38. 7.7.1 Creative-Biolabs Company Information
  39. 7.7.2 Creative-Biolabs Business Overview
  40. 7.7.3 Creative-Biolabs Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Creative-Biolabs Exosome Manufacturing Service Product Portfolio
  42. 7.7.5 Creative-Biolabs Recent Developments
  43. 7.8 Esco Aster
  44. 7.8.1 Esco Aster Company Information
  45. 7.8.2 Esco Aster Business Overview
  46. 7.8.3 Esco Aster Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Esco Aster Exosome Manufacturing Service Product Portfolio
  48. 7.8.5 Esco Aster Recent Developments
  49. 7.9 EXO Biologics
  50. 7.9.1 EXO Biologics Company Information
  51. 7.9.2 EXO Biologics Business Overview
  52. 7.9.3 EXO Biologics Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 EXO Biologics Exosome Manufacturing Service Product Portfolio
  54. 7.9.5 EXO Biologics Recent Developments
  55. 7.10 Eppendorf
  56. 7.10.1 Eppendorf Company Information
  57. 7.10.2 Eppendorf Business Overview
  58. 7.10.3 Eppendorf Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Eppendorf Exosome Manufacturing Service Product Portfolio
  60. 7.10.5 Eppendorf Recent Developments
  61. 7.11 Aethlon Medical
  62. 7.11.1 Aethlon Medical Company Information
  63. 7.11.2 Aethlon Medical Business Overview
  64. 7.11.3 Aethlon Medical Exosome Manufacturing Service Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Aethlon Medical Exosome Manufacturing Service Product Portfolio
  66. 7.11.5 Aethlon Medical Recent Developments
8 North America
  1. 8.1 North America Exosome Manufacturing Service Revenue (2021-2032)
  2. 8.2 North America Exosome Manufacturing Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Exosome Manufacturing Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Exosome Manufacturing Service Revenue by Type (2027-2032)
  5. 8.3 North America Exosome Manufacturing Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Exosome Manufacturing Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Exosome Manufacturing Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Exosome Manufacturing Service Revenue by Application (2027-2032)
  9. 8.5 North America Exosome Manufacturing Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Exosome Manufacturing Service Revenue by Country
  11. 8.6.1 North America Exosome Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Exosome Manufacturing Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Exosome Manufacturing Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Exosome Manufacturing Service Revenue (2021-2032)
  2. 9.2 Europe Exosome Manufacturing Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Exosome Manufacturing Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Exosome Manufacturing Service Revenue by Type (2027-2032)
  5. 9.3 Europe Exosome Manufacturing Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Exosome Manufacturing Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Exosome Manufacturing Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Exosome Manufacturing Service Revenue by Application (2027-2032)
  9. 9.5 Europe Exosome Manufacturing Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Exosome Manufacturing Service Revenue by Country
  11. 9.6.1 Europe Exosome Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Exosome Manufacturing Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Exosome Manufacturing Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Exosome Manufacturing Service Revenue (2021-2032)
  2. 10.2 China Exosome Manufacturing Service Revenue by Type (2021-2032)
  3. 10.2.1 China Exosome Manufacturing Service Revenue by Type (2021-2026)
  4. 10.2.2 China Exosome Manufacturing Service Revenue by Type (2027-2032)
  5. 10.3 China Exosome Manufacturing Service Revenue Share by Type (2021-2032)
  6. 10.4 China Exosome Manufacturing Service Revenue by Application (2021-2032)
  7. 10.4.1 China Exosome Manufacturing Service Revenue by Application (2021-2026)
  8. 10.4.2 China Exosome Manufacturing Service Revenue by Application (2027-2032)
  9. 10.5 China Exosome Manufacturing Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Exosome Manufacturing Service Revenue (2021-2032)
  2. 11.2 Asia Exosome Manufacturing Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Exosome Manufacturing Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Exosome Manufacturing Service Revenue by Type (2027-2032)
  5. 11.3 Asia Exosome Manufacturing Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Exosome Manufacturing Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Exosome Manufacturing Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Exosome Manufacturing Service Revenue by Application (2027-2032)
  9. 11.5 Asia Exosome Manufacturing Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Exosome Manufacturing Service Revenue by Country
  11. 11.6.1 Asia Exosome Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Exosome Manufacturing Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Exosome Manufacturing Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Exosome Manufacturing Service Revenue (2021-2032)
  2. 12.2 SAMEA Exosome Manufacturing Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Exosome Manufacturing Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Exosome Manufacturing Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Exosome Manufacturing Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Exosome Manufacturing Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Exosome Manufacturing Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Exosome Manufacturing Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Exosome Manufacturing Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Exosome Manufacturing Service Revenue by Country
  11. 12.6.1 SAMEA Exosome Manufacturing Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Exosome Manufacturing Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Exosome Manufacturing Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst